Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fujun Wang

Showing results (191-200 of 197) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 197 results.
Arthritis and Rheumatism|September 29, 2011
Development of responder definitions for fibromyalgia clinical trialsLesley M Arnold, David A Williams, James I Hudson, et al.
Immunotherapy|September 12, 2024
A phase 1 study of the CD40 agonist MEDI5083 in combination with durvalumab in patients with advanced solid tumorsBen Tran, Mark Voskoboynik, Johanna Bendell, et al.
Regenerative Biomaterials|July 6, 2026
Design of novel interlocked bi-layer NiTi braided stent with ultra-thin walls for urinary tract obstruction treatmentWenshuo Zhao, Jianjin Wang, Chenglong Yu, et al.
Advanced Materials (Deerfield Beach, Fla.)|June 18, 2024
Membrane Fusion-Mediated Loading of Therapeutic siRNA into Exosome for Tissue-Specific ApplicationMiao Xie, Yuqing Wu, Yilun Zhang, et al.
Leukemia & Lymphoma|October 15, 2024
Phase 1 first-in-human study of MEDI2228, a BCMA-targeted ADC, in patients with relapsed refractory multiple myelomaMeletios A Dimopoulos, Magdalini Migkou, Manisha Bhutani, et al.
Targeted Oncology|April 29, 2024
ASCT2-Targeting Antibody-Drug Conjugate MEDI7247 in Adult Patients with Relapsed/Refractory Hematological Malignancies: A First-in-Human, Phase 1 StudyMichael Maris, Gilles Salles, Won Seog Kim, et al.
BMC Medicine|October 9, 2023
Fotagliptin monotherapy with alogliptin as an active comparator in patients with uncontrolled type 2 diabetes mellitus: a randomized, multicenter, double-blind, placebo-controlled, phase 3 trialMingtong Xu, Kan Sun, Wenjie Xu, et al.
Pageof 20

Showing results (191-200 of 197) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 197 results.
Arthritis and Rheumatism|September 29, 2011
Development of responder definitions for fibromyalgia clinical trialsLesley M Arnold, David A Williams, James I Hudson, et al.
Immunotherapy|September 12, 2024
A phase 1 study of the CD40 agonist MEDI5083 in combination with durvalumab in patients with advanced solid tumorsBen Tran, Mark Voskoboynik, Johanna Bendell, et al.
Regenerative Biomaterials|July 6, 2026
Design of novel interlocked bi-layer NiTi braided stent with ultra-thin walls for urinary tract obstruction treatmentWenshuo Zhao, Jianjin Wang, Chenglong Yu, et al.
Advanced Materials (Deerfield Beach, Fla.)|June 18, 2024
Membrane Fusion-Mediated Loading of Therapeutic siRNA into Exosome for Tissue-Specific ApplicationMiao Xie, Yuqing Wu, Yilun Zhang, et al.
Leukemia & Lymphoma|October 15, 2024
Phase 1 first-in-human study of MEDI2228, a BCMA-targeted ADC, in patients with relapsed refractory multiple myelomaMeletios A Dimopoulos, Magdalini Migkou, Manisha Bhutani, et al.
Targeted Oncology|April 29, 2024
ASCT2-Targeting Antibody-Drug Conjugate MEDI7247 in Adult Patients with Relapsed/Refractory Hematological Malignancies: A First-in-Human, Phase 1 StudyMichael Maris, Gilles Salles, Won Seog Kim, et al.
BMC Medicine|October 9, 2023
Fotagliptin monotherapy with alogliptin as an active comparator in patients with uncontrolled type 2 diabetes mellitus: a randomized, multicenter, double-blind, placebo-controlled, phase 3 trialMingtong Xu, Kan Sun, Wenjie Xu, et al.
Pageof 20